As of 2023, over 400,000 Australians live with dementia, with over a million people assigned to their care. It is the second leading cause of death in the country overall and the leading cause of death in women. What’s worse, Australia’s growing ageing population makes this statistic all the more worrying. In a bid to
Read More
In a promising new chapter, Algorae Pharmaceuticals (ASX: 1AI), formerly known as Living Cell Technologies (ASX: LCT), has debuted its new name in a Memorandum of Understanding (MoU) with the University of New South Wales (UNSW). The MoU outlines a framework for a Master Services Research Agreement (MSRA) between both parties to develop an Artificial
Read More